San Jose, CA · Founded 2016 · Privately Held (backing)
Developer of sustained analgesic products designed to provide post-surgical pain management and recuperation for patients and physicians. Allay Therapeutics is based in San Jose, CA and was founded in 2016. It was valued at $126 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $175 million across 3 recorded rounds; the latest was a $45 million early-stage round in Jan 2025.
PMV mark · valuation
$126.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$174.8M
Last round
Early Stage VC
Jan 2025
No prints on record
No secondary trades in Allay Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allay Therapeutics with a free account
·The complete investor list: 19 names
·Watch Allay Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Allay Therapeutics stock.
